Question 1

What is STZ eyetrial known for?

Accepted Answer

In research, STZ eyetrial stands highest in Health Sciences (#3,824 of 9,902 worldwide) and Medicine (#3,565 of 8,541 worldwide), 2022-now. Relative to its size it is most specialised in Ophthalmology and Radiology, Nuclear Medicine and Imaging (Ophthalmology is 49.8× its share of world research).

Question 2

How does STZ eyetrial rank in research?

Accepted Answer

STZ eyetrial ranks #16,134 of 22,385 institutions worldwide on research quality in 2022-now (#14,208 all time), and #525 of 795 in Germany.

Question 3

Who are the top researchers at STZ eyetrial?

Accepted Answer

Ranked on the quality score, Bernd Wissinger, Susanne C Beck and Laura Kuehlewein lead among researchers whose main affiliation is STZ eyetrial.

Question 4

What are the most cited papers from STZ eyetrial?

Accepted Answer

The most cited paper from STZ eyetrial is "OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28" (Christiane Alexander, Marcela Votruba, Ulrike E. A. Pesch et al., 2000), with 1,336 citations. Next come "Glutathione, oxidative stress and neurodegeneration" (1,233) and "The art of using t-SNE for single-cell transcriptomics" (1,164).

Question 5

Which research topics does STZ eyetrial publish most on?

Accepted Answer

By volume in 2022-now: Retinal Development and Disorders, Retinal Diseases and Treatments, Glaucoma and retinal disorders and Ophthalmology and Visual Impairment Studies.

Question 6

Which keywords describe research at STZ eyetrial?

Accepted Answer

By fractional works in 2022-now, weighted toward what it does more of than the world: Macular Degeneration, Gene Therapy, Vascular Endothelial Growth Factor, Retinal Stem Cells, Retinitis Pigmentosa, Diabetic Retinopathy, Myopia and Inflammation.

Question 7

Which fields of science does STZ eyetrial work in?

Accepted Answer

In 2022-now, 60% of research at STZ eyetrial is in Health Sciences, 29% in Life Sciences. Its largest fields are Medicine (59%), Biochemistry, Genetics and Molecular Biology (18%), Neuroscience (8%). It does 2.5× the world's share of Health Sciences.

Question 8

Is STZ eyetrial's research output growing?

Accepted Answer

Output in 2022-2025 was 8% lower than in 2018-2021.